A Dose-Ranging Study of the Effect of Glycopyrrolate in Subjects With Axillary Hyperhidrosis

PHASE2CompletedINTERVENTIONAL
Enrollment

198

Participants

Timeline

Start Date

November 30, 2013

Primary Completion Date

September 30, 2014

Study Completion Date

September 30, 2014

Conditions
Hyperhidrosis
Interventions
DRUG

glycopyrrolate, 1.0%

glycopyrrolate Topical Wipes, 1.0%

DRUG

glycopyrrolate, 2.0%

glycopyrrolate Topical Wipes, 2.0%

DRUG

glycopyrrolate, 3.0%

glycopyrrolate Topical Wipes, 3.0%

DRUG

glycopyrrolate, 4.0%

glycopyrrolate Topical Wipes, 4.0%

OTHER

Vehicle

Vehicle Topical Wipes

Trial Locations (21)

23233

Westend Dermatology Associates, Richmond

23507

Virginia Clinical Research, Inc., Norfolk

33136

Florida Academic Dermatology Center, Miami

33401

Kenneth R. Beer, MD, PA, West Palm Beach

46032

Shideler Clinical Research Center, Carmel

55432

Minnesota Clinical Study Center, Fridley

63122

Saint Louis University Dermatology, St Louis

67226

Cypress Medical Research Center, LLC, Wichita

68144

Skin Specialists, PC, Omaha

71913

Burke Pharmaceutical Research, Hot Springs

72202

Gary M. Petrus, MD, PA, Little Rock

77845

J&S Studies, Inc., College Station

78229

Clinical Trials of Texas, Inc., San Antonio

84117

Dermatology Research Center, Inc., Salt Lake City

92024

California Dermatology & Clinical Research Institute, Encinitas

94538

Center For Dermatology Clinical Research, Fremont

97223

Oregon Medical Research Center, Portland

98101

Dermatology Associates, Seattle

98105

Women's Clinical Research Center, Seattle

99204

Premier Clinical Research, Spokane

07044

The Dermatology Group, PC, Verona

Sponsors
All Listed Sponsors
lead

Journey Medical Corporation

INDUSTRY

NCT02016885 - A Dose-Ranging Study of the Effect of Glycopyrrolate in Subjects With Axillary Hyperhidrosis | Biotech Hunter | Biotech Hunter